Table 1. Clinical and pathological parameters of CCRCC patients (n = 59).
| Patients | Average (%) |
|---|---|
| Age (range) | 59 (25–83) |
| Sex | |
| Male | 45 (76%) |
| Female | 14 (24%) |
| Follow-up (months) | 65 (1–240) |
| Survival | |
| Alive | 21 (36%) |
| Dead of disease | 38 (64%) |
| Primary tumor | n |
| Diameter | |
| ≤ 7cm | 34 (58%) |
| > 7cm | 25 (42%) |
| Grouped grade | |
| Low (G1-G2) | 24 (41%) |
| High (G3-G4) | 35 (59%) |
| Grouped pT* | |
| Low (pT1-pT2) | 32 (54%) |
| High (pT3-pT4) | 27 (46%) |
| Sarcomatoid | |
| No | 55 (93%) |
| Yes | 4 (7%) |
| Necrosis | |
| No | 29 (49%) |
| Yes | 30 (51%) |
| Metastases | n |
| Synchronous | 14 (24%) |
| Metachronous | 45 (76%) |
| Location | |
| Lymphatic nodes | 12 (20%) |
| Epithelial tissues | 31 (53%) |
| Soft/bone tissues | 16 (27%) |
(*) Grouped pT: organ confined (pT1-pT2) vs non organ confined (pT3-pT4) disease